<DOC>
	<DOCNO>NCT01564459</DOCNO>
	<brief_summary>The purpose study evaluate safety effectiveness MK-6096 treatment painful diabetic neuropathy ( PDN ) adult .</brief_summary>
	<brief_title>Study Evaluate MK-6096 Treatment Painful Diabetic Neuropathy ( PDN ) Adults ( MK-6096-021 )</brief_title>
	<detailed_description />
	<mesh_term>Pain</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<criteria>Has primary diagnosis painful diabetic neuropathy ( PDN ) least 6 month . Is able understand &amp; use electronic diary complete daily questionnaire . If female reproductive potential , agree use acceptable contraception Screening least 2 week last dose study drug . Is stable dose antihyperglycemic treatment least 1 month , hemoglobin A1C level 11 % . If take allowable aroundtheclock medication chronic pain , stable dose least 1 month &amp; agree stay dose study . Agrees start therapy opioids , pregabalin , gabapentin , duloxetine medication use treat neuropathic pain study . Has regular bedtime 1 AM ( 01:00 ) . Agrees limit alcohol consumption 3 drink day , drink within 3 hour bedtime . One drink define : 1 ) 12 ounce beer ; 2 ) 4 ounce wine ; 3 ) 1 ounce liquor ( 80 proof 40 % alcohol ) . Agrees limit caffeine consumption 5 standard 6oz . cup caffeinated beverage 600 mg caffeine day , caffeinated beverage 4 PM ( 16:00 ) . Agrees maintain relatively consistent level activity throughout study . Is pregnant breastfeeding , expect become pregnant study . Expects donate egg sperm study within 90 day last dose study drug . Has ineffective treatment 3 neuropathic pain drug . Anticipates need surgery study . Has another exist type pain severe great pain study OR able distinguish pain study another exist pain condition . Has post herpetic neuralgia ( PHN ) ; small fiber predominant neuropathy ( SFN ) ; idiopathic sensory neuropathy ( ISN ) ; complex regional pain syndrome ; sensory neuropathy ; pain cause radiation/chemotherapy/amputation/human immunodeficiency virus ( HIV ) infection . Has receive nerve block pain within past 6 week . Has history pernicious anemia , untreated hypothyroidism , amputation toe . Has history narcolepsy , cataplexy , circadian rhythm disorder , parasomnia , sleeprelated breathe disorder , restless legs syndrome , periodic limb movement disorder , excessive daytime sleepiness , difficulty sleep due medical condition ( i.e . asthma , Gastroesophageal Reflux Disease ( GERD ) ) PDN . Has history neurological disorder , include : seizure disorder , stroke , transient ischemic attack , multiple sclerosis , cognitive impairment , significant head trauma sustain loss consciousness . Has current evidence history within past 6 month unstable cardiovascular disorder , include : acute coronary syndrome ; unstable angina ; congestive heart failure ; cardiogenic syncope ; cardiomyopathy ; symptomatic arrhythmia . Has Body Mass Index ( BMI ) 40 kg/m^2 . Has follow : 1 ) evidence ongoing depression suicidality ; 2 ) lifetime history bipolar disorder , psychotic disorder , posttraumatic stress disorder ; 3 ) psychiatric condition require treatment prohibit medication ; 3 ) current psychiatric condition might interfere ability participate study . Is imminent risk selfharm harm others . Has history substance abuse dependence . Substances include alcohol , marijuana , hypnotic , prescription drug , &amp; drug abuse , exclude nicotine . Has history malignant cancer within past 5 year , except adequately treat basal cell squamous cell skin cancer cervical cancer . Has history hypersensitivity reaction 2 chemical class drug , include prescription &amp; overthecounter medication . Is currently participate participate investigational study compound device within past 30 day OR willing refrain participate another study study . Has history travel across 3 time zone shift work ( permanent night shift rotate day/night shift work ) within past 2 week , OR anticipate need travel across 3 time zone study . Has donate blood product 300 mL blood drawn within past 8 week ; receive blood product within past 30 day ; OR intend donate receive blood product study . Has previously participate study MK6096 . Is employee and/or family member one investigator , study staff , Merck .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>